🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 2 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/07/2010 | 47,94 | 48,03 | 46,62 | 47,79 | -0,02% | 2,94% | 788.000 |
| 06/07/2010 | 49,42 | 49,46 | 47,49 | 47,80 | -2,03% | 3,99% | 594.600 |
| 02/07/2010 | 48,62 | 49,48 | 48,62 | 48,79 | +0,85% | 1,77% | 396.600 |
| 01/07/2010 | 48,78 | 49,03 | 47,26 | 48,38 | -0,88% | 3,63% | 495.600 |
| 30/06/2010 | 48,86 | 49,78 | 48,80 | 48,81 | -0,39% | 2,01% | 388.900 |
| 29/06/2010 | 51,12 | 51,12 | 48,86 | 49,00 | -5,35% | 4,42% | 985.000 |
| 28/06/2010 | 52,45 | 52,57 | 51,65 | 51,77 | -0,99% | 1,75% | 547.300 |
| 25/06/2010 | 51,85 | 52,93 | 51,21 | 52,29 | +0,97% | 3,32% | 806.900 |
| 24/06/2010 | 52,63 | 53,36 | 51,64 | 51,79 | -1,76% | 3,27% | 765.600 |
| 23/06/2010 | 52,84 | 52,96 | 51,88 | 52,72 | -0,47% | 2,04% | 672.600 |
| 22/06/2010 | 53,67 | 54,18 | 52,85 | 52,97 | -1,21% | 2,48% | 374.600 |
| 21/06/2010 | 54,81 | 55,00 | 53,31 | 53,62 | -1,31% | 3,08% | 302.500 |
| 18/06/2010 | 54,49 | 54,95 | 54,19 | 54,33 | -0,29% | 1,39% | 516.800 |
| 17/06/2010 | 54,45 | 54,92 | 53,90 | 54,49 | -1,11% | 1,87% | 342.700 |
| 16/06/2010 | 55,03 | 55,51 | 54,83 | 55,10 | -0,61% | 1,24% | 463.300 |
| 15/06/2010 | 54,46 | 55,47 | 54,31 | 55,44 | +2,78% | 2,13% | 723.800 |
| 14/06/2010 | 54,33 | 55,07 | 53,84 | 53,94 | -0,33% | 2,26% | 535.600 |
| 11/06/2010 | 54,01 | 54,91 | 53,80 | 54,12 | -0,44% | 2,06% | 416.600 |
| 10/06/2010 | 53,47 | 54,45 | 53,24 | 54,36 | +5,55% | 2,26% | 866.700 |
| 09/06/2010 | 51,66 | 52,19 | 51,11 | 51,50 | +0,57% | 2,09% | 479.200 |
| 08/06/2010 | 51,76 | 51,98 | 50,22 | 51,21 | -0,60% | 3,40% | 709.100 |
| 07/06/2010 | 51,32 | 51,68 | 50,79 | 51,52 | +0,64% | 1,73% | 605.900 |
| 04/06/2010 | 52,34 | 52,34 | 50,87 | 51,19 | -2,70% | 2,81% | 342.900 |
| 03/06/2010 | 52,48 | 52,83 | 51,84 | 52,61 | +0,06% | 1,89% | 312.600 |
| 02/06/2010 | 50,47 | 52,71 | 50,43 | 52,58 | +4,74% | 4,52% | 652.200 |
| 01/06/2010 | 50,93 | 51,52 | 50,15 | 50,20 | -1,99% | 2,69% | 470.700 |
| 28/05/2010 | 52,10 | 52,63 | 51,13 | 51,22 | -2,12% | 2,88% | 585.200 |
| 27/05/2010 | 52,00 | 52,33 | 51,67 | 52,33 | +2,21% | 1,27% | 433.900 |
| 26/05/2010 | 50,55 | 51,98 | 50,27 | 51,20 | +1,13% | 3,38% | 797.900 |
| 25/05/2010 | 51,03 | 51,03 | 49,65 | 50,63 | -2,56% | 2,70% | 912.200 |